Patent status

GB grant (2527164), EP application (15701566.0)

Commercial rights

Sole Rights / Non-exclusive





Available to license


Project number


Determine the onset of sepsis days before clinical symptoms appear in the patient.

Diagnosed cases of sepsis exceed 18 million a year with 1,400 patients dying daily in the developed world. Rapid treatment is critical to a patient’s recovery and therefore the time taken to diagnose sepsis is key.

This new technique is not dependent upon needing the symptoms of sepsis to be clinically displayed. Instead, a set of biomarkers are used in suspected patients to diagnose the presence of sepsis before the symptoms appear.

This allows the identification of sepsis in a patient much earlier, extending the treatment window and making it more effective.


  • Therapeutic window extended and mortality rates reduced
  • Cost of treatment lowered
  • Can discriminate between sepsis, SIRS, and negative controls
  • Compatible with RT-qPCR formats for rapid results

Want to read more?

Download our data sheet

By providing your email address you are confirming you are happy for us to contact you.